0.2921
3.29%
+0.0093
After Hours:
.293
0.0009
+0.31%
Aclarion Inc stock is currently priced at $0.2921, with a 24-hour trading volume of 340.15K.
It has seen a +3.29% increased in the last 24 hours and a -9.54% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $0.2879 pivot point. If it approaches the $0.2949 resistance level, significant changes may occur.
Previous Close:
$0.2828
Open:
$0.3
24h Volume:
340.15K
Market Cap:
$2.09M
Revenue:
$75,400
Net Income/Loss:
$-4.91M
P/E Ratio:
-0.5216
EPS:
-0.56
Net Cash Flow:
$-3.77M
1W Performance:
-13.32%
1M Performance:
-9.54%
6M Performance:
-12.10%
1Y Performance:
-65.64%
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
650-241-1741
Address
951 Mariners Island Boulevard, Suite 300, San Mateo
Aclarion Inc Stock (ACON) Latest News
Spotting Penny Stocks Uptrends, 3 Top Tips
PennyStocks
Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain
GlobeNewswire Inc.
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Aclarion Announces Closing of $3.0 Million Public Offering
GlobeNewswire Inc.
Gold Moves Lower; Pilgrim's Pride Earnings Top Views
Benzinga
Aclarion Inc Stock (ACON) Financials Data
Aclarion Inc (ACON) Revenue 2024
ACON reported a revenue (TTM) of $75.40 thousand for the quarter ending December 31, 2023, a +24.83% rise year-over-year.
Aclarion Inc (ACON) Net Income 2024
ACON net income (TTM) was -$4.91 million for the quarter ending December 31, 2023, a +30.52% increase year-over-year.
Aclarion Inc (ACON) Cash Flow 2024
ACON recorded a free cash flow (TTM) of -$3.77 million for the quarter ending December 31, 2023, a +26.98% increase year-over-year.
Aclarion Inc (ACON) Earnings per Share 2024
ACON earnings per share (TTM) was -$8.98 for the quarter ending December 31, 2023, a +38.27% growth year-over-year.
About Aclarion Inc
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Cap:
|
Volume (24h):